JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.28% |
| 2 | Technology | 15.04% |
| 3 | Healthcare | 12.52% |
| 4 | Financials | 10.55% |
| 5 | Consumer Discretionary | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4001
Camtek
CAMT
$7.71B
| $873K | ﹤0.01% |
35,147
-3,026
| -8% | -$86.5K |
2020 Q2
8 quarters
|
|
|
SFT
4002
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
| $872K | ﹤0.01% |
129,579
-14,139
| -10% | -$174K |
2021 Q1
5 quarters
|
|
|
CNTA
4003
DELISTED
Centessa Pharmaceuticals
CNTA
| $869K | ﹤0.01% |
178,414
+173,698
| +3,683% | +$1.11M |
2021 Q2
4 quarters
|
|
4004
Orion
OEC
$327M
| $869K | ﹤0.01% |
55,967
+6,248
| +13% | +$105K |
2016 Q1
25 quarters
|
|
|
BZAI
4005
Blaize Holdings
BZAI
$69.5M
| $869K | ﹤0.01% |
87,437
| – | – |
2022 Q1
1 quarter
|
|
4006
German American Bancorp
GABC
$1.86B
| $868K | ﹤0.01% |
25,396
+173
| +0.7% | +$6.27K |
2013 Q2
36 quarters
|
|
4007
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.75B
| $868K | ﹤0.01% |
26,488
-8,286
| -24% | -$297K |
2014 Q1
33 quarters
|
|
|
INVX
4008
Innovex International
INVX
$1.91B
| $868K | ﹤0.01% |
33,686
+5,084
| +18% | +$155K |
2013 Q2
36 quarters
|
|
4009
Tompkins Financial
TMP
$1.42B
| $867K | ﹤0.01% |
12,021
-10,884
| -48% | -$806K |
2013 Q2
36 quarters
|
|
|
XYZ
4010
CALL
Block Inc
XYZ
$44.7B
| $867K | ﹤0.01% |
14,100
-15,600
| -53% | -$1.43M |
2020 Q4
6 quarters
|
|
|
EQD
4011
DELISTED
Equity Distribution Acquisition Corp.
EQD
| $866K | ﹤0.01% |
87,182
-11,641
| -12% | -$115K |
2021 Q1
5 quarters
|
|
4012
Payoneer
PAYO
$2.42B
| $865K | ﹤0.01% |
220,450
+161,401
| +273% | +$719K |
2021 Q3
3 quarters
|
|
4013
PUT
Yeti Holdings
YETI
$2.98B
| $865K | ﹤0.01% |
20,000
| – | – |
2022 Q1
1 quarter
|
|
|
BNFT
4014
DELISTED
Benefitfocus, Inc.
BNFT
| $863K | ﹤0.01% |
110,980
-5,429
| -5% | -$53.6K |
2017 Q4
18 quarters
|
|
4015
SSR Mining
SSRM
$6.78B
| $860K | ﹤0.01% |
51,490
-245,620
| -83% | -$5.07M |
2020 Q3
7 quarters
|
|
|
CDAQU
4016
DELISTED
Compass Digital Acquisition Corp. Unit
CDAQU
| $860K | ﹤0.01% |
89,154
-99,856
| -53% | -$973K |
2021 Q4
2 quarters
|
|
4017
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.24B
| $859K | ﹤0.01% |
24,660
-2,844
| -10% | -$109K |
2013 Q2
36 quarters
|
|
|
CDMO
4018
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $858K | ﹤0.01% |
56,276
+10,292
| +22% | +$152K |
2015 Q1
29 quarters
|
|
|
SCUA
4019
DELISTED
Sculptor Acquisition Corp I
SCUA
| $856K | ﹤0.01% |
86,300
| – | – |
2022 Q1
1 quarter
|
|
4020
Sociedad Química y Minera de Chile
SQM
$18.4B
| $855K | ﹤0.01% |
10,234
-104,317
| -91% | -$9.18M |
2014 Q1
33 quarters
|
|
|
LYLT
4021
DELISTED
Loyalty Ventures Inc. Common Stock
LYLT
| $855K | ﹤0.01% |
239,621
+173,576
| +263% | +$1.86M |
2021 Q4
2 quarters
|
|
4022
Tilray
TLRY
$533M
| $854K | ﹤0.01% |
27,374
+681
| +3% | +$32.2K |
2018 Q3
15 quarters
|
|
4023
PUT
Upstart Holdings
UPST
$2.22B
| $854K | ﹤0.01% |
+27,000
| New | +$1.61M |
2022 Q2
0 quarters
|
|
|
VLATU
4024
DELISTED
Valor Latitude Acquisition Corp. Unit
VLATU
| $854K | ﹤0.01% |
87,267
-111,253
| -56% | -$1.09M |
2022 Q1
1 quarter
|
|
4025
Vor Biopharma
VOR
$1.11B
| $852K | ﹤0.01% |
8,569
-590
| -6% | -$60.4K |
2021 Q1
5 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,728 reduced and 609 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 609 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.